Cargando…
The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas
The oncogenic transcription factor Myc is required for the progression and maintenance of diverse tumors. This has led to the concept that Myc itself, Myc-activated gene products, or associated biological processes might constitute prime targets for cancer therapy. Here, we present an in vivo revers...
Autores principales: | D'Andrea, Aleco, Gritti, Ilaria, Nicoli, Paola, Giorgio, Marco, Doni, Mirko, Conti, Annalisa, Bianchi, Valerio, Casoli, Lucia, Sabò, Arianna, Mironov, Alexandre, Beznoussenko, Galina V., Amati, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341918/ https://www.ncbi.nlm.nih.gov/pubmed/27635472 http://dx.doi.org/10.18632/oncotarget.11719 |
Ejemplares similares
-
Smyd2 is a Myc-regulated gene critical for MLL-AF9 induced leukemogenesis
por: Bagislar, Sevgi, et al.
Publicado: (2016) -
SUMOylation of Myc-Family Proteins
por: Sabò, Arianna, et al.
Publicado: (2014) -
Genome-wide analysis of p53 transcriptional programs in B cells upon exposure to genotoxic stress in vivo
por: Tonelli, Claudia, et al.
Publicado: (2015) -
Polycomb group ring finger protein 6 suppresses Myc-induced lymphomagenesis
por: Tanaskovic, Nina, et al.
Publicado: (2022) -
Integrative analysis of RNA polymerase II and transcriptional dynamics upon MYC activation
por: de Pretis, Stefano, et al.
Publicado: (2017)